4.5 Article

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Genetics & Heredity

Inheritance of the chronic myeloproliferative neoplasms. A systematic review

A. Ranjan et al.

CLINICAL GENETICS (2013)

Article Hematology

Risk models predicting survival after reduced-intensity transplantation for myelofibrosis

Haefaa Alchalby et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Article Medicine, General & Internal

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srdan Verstovsek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Claire Harrison et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Serious Adverse Events During Ruxolitinib Treatment Discontinuation in Patients With Myelofibrosis

Ayalew Tefferi et al.

MAYO CLINIC PROCEEDINGS (2011)

Article Hematology

Outcome of Transplantation for Myelofibrosis

Karen K. Ballen et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)

Review Medicine, General & Internal

Graft-versus-host disease

James L. M. Ferrara et al.

LANCET (2009)